InterCure (INCR) Revenue & Revenue Breakdown
InterCure Revenue Highlights
Latest Revenue (Y)
$355.55M
Latest Revenue (Q)
$73.47M
InterCure Revenue by Period
InterCure Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $355.55M | -8.52% |
| 2022-12-31 | $388.68M | 76.93% |
| 2021-12-31 | $219.68M | 237.78% |
| 2020-12-31 | $65.03M | 628.60% |
| 2019-12-31 | $8.93M | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | -100.00% |
| 2015-12-31 | $1.40M | -75.20% |
| 2014-12-31 | $5.65M | -31.51% |
| 2013-12-31 | $8.25M | -2.59% |
| 2012-12-31 | $8.47M | -29.82% |
| 2011-12-31 | $12.07M | -8.76% |
| 2010-12-31 | $13.23M | - |
InterCure generated $355.55M in revenue during NA 2023, up -8.52% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
InterCure Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $73.47M | - |
| 2023-09-30 | $73.47M | -28.28% |
| 2023-06-30 | $102.44M | -3.52% |
| 2023-03-31 | $106.17M | 0.54% |
| 2022-12-31 | $105.61M | 5.01% |
| 2022-09-30 | $100.57M | 5.56% |
| 2022-06-30 | $95.28M | 9.23% |
| 2022-03-31 | $87.23M | 9.45% |
| 2021-12-31 | $79.70M | 29.19% |
| 2021-09-30 | $61.70M | 36.40% |
| 2021-06-30 | $45.23M | 36.85% |
| 2021-03-31 | $33.05M | 21.99% |
| 2020-12-31 | $27.09M | 20.43% |
| 2020-09-30 | $22.50M | 101.14% |
| 2020-06-30 | $11.19M | 162.62% |
| 2020-03-31 | $4.26M | 132.99% |
| 2019-12-31 | $1.83M | -29.64% |
| 2019-09-30 | $2.60M | -6.45% |
| 2019-06-30 | $2.78M | 61.17% |
| 2019-03-31 | $1.72M | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | -100.00% |
| 2015-12-31 | $49.80K | -85.09% |
| 2015-09-30 | $333.98K | -26.98% |
| 2015-06-30 | $457.35K | -16.24% |
| 2015-03-31 | $546.04K | -46.90% |
| 2014-12-31 | $1.03M | -2.77% |
| 2014-09-30 | $1.06M | -18.91% |
| 2014-06-30 | $1.30M | -36.54% |
| 2014-03-31 | $2.06M | -11.94% |
| 2013-12-31 | $2.33M | 38.32% |
| 2013-09-30 | $1.69M | -9.64% |
| 2013-06-30 | $1.87M | -24.04% |
| 2013-03-31 | $2.46M | 30.56% |
| 2012-12-31 | $1.88M | 2.16% |
| 2012-09-30 | $1.84M | -15.73% |
| 2012-06-30 | $2.19M | -8.71% |
| 2012-03-31 | $2.40M | -20.59% |
| 2011-12-31 | $3.02M | - |
| 2011-09-30 | $3.02M | - |
| 2011-06-30 | $3.02M | - |
| 2011-03-31 | $3.02M | -8.76% |
| 2010-12-31 | $3.31M | - |
| 2010-09-30 | $3.31M | - |
| 2010-06-30 | $3.31M | - |
| 2010-03-31 | $3.31M | - |
InterCure generated $73.47M in revenue during Q4 2023, up 0.00% compared to the previous quarter, and up 73.05% compared to the same period a year ago.
InterCure Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| PBH | Prestige Consumer Healthcare | $1.13B | $283.55M |
| PAHC | Phibro Animal Health | $977.89M | $273.16M |
| PCRX | Pacira BioSciences | $674.98M | $168.57M |
| COLL | Collegium Pharmaceutical | $566.77M | $159.30M |
| INCR | InterCure | $355.55M | $73.47M |
| IXHL | Incannex Healthcare | - | $12.00K |
| RGC | Regencell Bioscience | - | - |